GeoPolitics Pulse

The Heartbeat of World events

Sugemalimab Plus Chemotherapy Earns UK Approval in First-Line Metastatic NSCLC

by ·

The United Kingdom’s (UK) Medicines and Healthcare products Regulatory Agency has approved sugemalimab (Cejemly) plus platinum-based chemotherapy …Read More

Related posts:

  1. CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First …
  2. FRUZAQLA Receives European Commission Approval for Metastatic Colorectal Cancer Treatment
  3. ‘Loving and being loved’: UK’s Princess Kate says she is grateful after finishing chemotherapy
  4. Iran: Patients Injected with Distilled Water Instead of Chemotherapy Drugs
  5. Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy …